Uday B. Kompella

10.7k total citations
195 papers, 8.0k citations indexed

About

Uday B. Kompella is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Uday B. Kompella has authored 195 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 70 papers in Ophthalmology and 37 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Uday B. Kompella's work include Retinal Diseases and Treatments (46 papers), Glaucoma and retinal disorders (38 papers) and Advanced Drug Delivery Systems (30 papers). Uday B. Kompella is often cited by papers focused on Retinal Diseases and Treatments (46 papers), Glaucoma and retinal disorders (38 papers) and Advanced Drug Delivery Systems (30 papers). Uday B. Kompella collaborates with scholars based in United States, India and China. Uday B. Kompella's co-authors include Surya Ayalasomayajula, Rajendra S. Kadam, Aniruddha Amrite, Ruchit Trivedi, Nagesh Bandi, Puneet Tyagi, Henry F. Edelhauser, N. Cheruvu, Shelley A. Durazo and Swita Raghava and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Uday B. Kompella

192 papers receiving 7.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uday B. Kompella United States 54 2.8k 2.2k 2.0k 1.7k 1.4k 195 8.0k
Arto Urtti Finland 66 7.6k 2.7× 2.7k 1.2× 4.9k 2.5× 2.2k 1.3× 2.6k 1.9× 418 17.9k
Ashim K. Mitra United States 39 1.7k 0.6× 700 0.3× 1.7k 0.8× 662 0.4× 857 0.6× 135 4.8k
Dhananjay Pal United States 38 1.6k 0.6× 659 0.3× 1.3k 0.6× 639 0.4× 876 0.6× 165 5.1k
Ilva D. Rupenthal New Zealand 36 1.4k 0.5× 884 0.4× 1.3k 0.6× 772 0.5× 1.1k 0.8× 120 3.7k
Anuj Chauhan United States 41 552 0.2× 1.2k 0.5× 2.9k 1.4× 1.2k 0.7× 3.5k 2.6× 157 5.7k
Anil K. Mishra India 47 2.4k 0.9× 115 0.1× 2.1k 1.1× 1.2k 0.7× 379 0.3× 286 7.6k
Rosario Pignatello Italy 41 1.7k 0.6× 237 0.1× 2.3k 1.2× 258 0.2× 544 0.4× 196 5.8k
Xing Tang China 51 2.8k 1.0× 172 0.1× 2.7k 1.4× 309 0.2× 411 0.3× 349 8.9k
Jaleh Barar Iran 53 3.0k 1.1× 152 0.1× 1.0k 0.5× 602 0.4× 331 0.2× 208 7.9k
Mark Kester United States 54 6.4k 2.3× 700 0.3× 176 0.1× 485 0.3× 208 0.2× 222 11.2k

Countries citing papers authored by Uday B. Kompella

Since Specialization
Citations

This map shows the geographic impact of Uday B. Kompella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uday B. Kompella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uday B. Kompella more than expected).

Fields of papers citing papers by Uday B. Kompella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uday B. Kompella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uday B. Kompella. The network helps show where Uday B. Kompella may publish in the future.

Co-authorship network of co-authors of Uday B. Kompella

This figure shows the co-authorship network connecting the top 25 collaborators of Uday B. Kompella. A scholar is included among the top collaborators of Uday B. Kompella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uday B. Kompella. Uday B. Kompella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dey, Aishee, et al.. (2025). Pharmacokinetic model for drug delivery by Ozurdex. Drug Delivery and Translational Research. 16(4). 1249–1261.
2.
Awolade, Paul, Qiong Zhou, Hector Esquer, et al.. (2023). The validation of new CHD1L inhibitors as a therapeutic strategy for cancer. Biomedicine & Pharmacotherapy. 170. 116037–116037. 2 indexed citations
3.
Prigaro, Brett J., Hector Esquer, Qiong Zhou, et al.. (2022). Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L. Journal of Medicinal Chemistry. 65(5). 3943–3961. 11 indexed citations
4.
Anupama, C., et al.. (2021). Oxidative Stress Induces a Breakdown of the Cytoskeleton and Tight Junctions of the Corneal Endothelial Cells. Journal of Ocular Pharmacology and Therapeutics. 38(1). 74–84. 17 indexed citations
5.
Bourne, David W. A., Jiban Jyoti Panda, Stephanie Choi, et al.. (2020). Effect of Particle Size and Viscosity of Suspensions on Topical Ocular Bioavailability of Budesonide, a Corticosteroid. Journal of Ocular Pharmacology and Therapeutics. 36(6). 404–409. 8 indexed citations
6.
Damiati, Samar, et al.. (2018). Microfluidic Devices for Drug Delivery Systems and Drug Screening. Genes. 9(2). 103–103. 279 indexed citations
7.
Muralidharan, Ranganayaki, Anish Babu, Narsireddy Amreddy, et al.. (2017). Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR. Molecular Cancer Therapeutics. 16(8). 1470–1486. 55 indexed citations
8.
Matter, Brock, Alireza Ghaffari, David W. A. Bourne, et al.. (2016). Dexamethasone Degradation During In Vitro Release from an Intravitreal Implant. Investigative Ophthalmology & Visual Science. 57(12). 4010–4010. 1 indexed citations
9.
Wang, Yueren, et al.. (2013). Depth resolved fluorescence lifetime of fluorescein across the cornea. Investigative Ophthalmology & Visual Science. 54(15). 2607–2607. 3 indexed citations
10.
Kompella, Uday B. & Arun K. Upadhyay. (2012). Trasferrin-functionalized PLGA Nanopartilces Sustain Diclofenac Delivery to Choroid-RPE. Investigative Ophthalmology & Visual Science. 53(14). 451–451. 1 indexed citations
11.
Guha, Sonia, et al.. (2011). Acidic Nanoparticles Enhance Degradative Lysosomal Enzyme Activity In Compromised Rpe Cells. Investigative Ophthalmology & Visual Science. 52(14). 3216–3216. 1 indexed citations
12.
Missel, Paul J., James E. Chastain, Ashim K. Mitra, et al.. (2010). In Vitro Transport and Partitioning of AL-4940, Active Metabolite of Angiostatic Agent Anecortave Acetate, in Ocular Tissues of the Posterior Segment. Journal of Ocular Pharmacology and Therapeutics. 26(2). 137–146. 14 indexed citations
13.
Pan, Carolyn K., Chandrasekar Durairaj, Uday B. Kompella, et al.. (2010). Comparison of Long-Acting Bevacizumab Formulations in the Treatment of Choroidal Neovascularization in a Rat Model. Investigative Ophthalmology & Visual Science. 51(13). 2457–2457. 1 indexed citations
14.
Kannan, Ram, Parameswaran G. Sreekumar, Stephen J. Ryan, et al.. (2010). Alpha Crystallin Derived Peptide Chaperone Protects Human RPE Cells From Oxidative Injury. Investigative Ophthalmology & Visual Science. 51(13). 1441–1441. 3 indexed citations
15.
Raghava, Swita, Henry F. Edelhauser, Hans E. Grossniklaus, B.K. Ambati, & Uday B. Kompella. (2008). Intravenous Transferrin, RGD Peptide, and Dual Targeted Nanoparticles Enhance VEGF Intraceptor Gene Delivery to Laser Induced Choroidal Neovascularization Lesions. Investigative Ophthalmology & Visual Science. 49(13). 4805–4805. 1 indexed citations
16.
Amrite, Aniruddha & Uday B. Kompella. (2007). Celecoxib Inhibits Proliferation of Retinal Pigment Epithelial and Choroid-Retinal Endothelial Cells by a Cyclooxygenase-2-Independent Mechanism. Journal of Pharmacology and Experimental Therapeutics. 324(2). 749–758. 29 indexed citations
17.
Mo, Yi, Micheal E. Barnett, Swita Raghava, D.J. Takemoto, & Uday B. Kompella. (2007). Human Serum Albumin Nanoparticles for Efficient Retinal Gene Delivery. Investigative Ophthalmology & Visual Science. 48(13). 3189–3189. 1 indexed citations
18.
Cheruvu, N., et al.. (2005). Transscleral Transport: Barrier Properties of Sclera, Choroid–Tapetum, and Retinal Pigment Epithelium. Investigative Ophthalmology & Visual Science. 46(13). 5390–5390. 2 indexed citations
19.
Bandi, Nagesh & Uday B. Kompella. (2002). Budesonide reduces multidrug resistance-associated protein 1 expression in an airway epithelial cell line (Calu-1). European Journal of Pharmacology. 437(1-2). 9–17. 30 indexed citations
20.
Kompella, Uday B., et al.. (1998). Effect of Liposomal Charge on Stavudine Transport Across Rabbit Cornea and Conjunctiva. Pharmacy and Pharmacology Communications. 4(7). 339–343. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026